How are drugs approved?

Cancer drugs

The pan-Canadian Oncology Drug Review (pCODR) assesses cancer drugs and recommends which ones Ontario and other provinces and territories in Canada (except Quebec) should fund under their public drug programs.  The review takes up to 5-8 months to complete. There are 4 main steps:

  1. pCODR works with the manufacturer or tumour group to help them prepare for the review. This includes obtaining input from the Provincial Advisory Group and patient stakeholder groups.
  2. The manufacturer or tumour group submits its request for a drug review. Its submission must follow a strict set of guidelines.
  3. An expert pCODR review committee considers the research data and cost of the proposed drug. This includes a review of input from the Provincial Advisory Group and other stakeholders.
  4. The pCODR then recommends if the cancer drug should be publicly funded.

Learn more about the pCODR process from their website.

The final step for approval

For More Information

Call ServiceOntario, Infoline at 1-866-532-3161
In Toronto, 416-314-5518
TTY 1-800-387-5559
In Toronto, TTY 416-327-4282
Hours of operation : 8:30am - 5:00pm